This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignee: Lek Pharmaceuticals D.d.. Active years: 2013-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2015
Title: Polona Jurkovic: Innovator in Pharmaceutical Composition
Introduction
Polona Jurkovic is a prominent inventor based in Ljubljana, Slovenia. She has made significant contributions to the pharmaceutical industry, particularly in the development of innovative drug delivery systems and compositions.
Latest Patents
Polona Jurkovic holds 2 patents that showcase her expertise in pharmaceutical formulations. Her latest patents include a process for the preparation of a pharmaceutical composition comprising ezetimibe. This invention focuses on creating dosage forms that contain ezetimibe, along with a combination of ezetimibe and simvastatin, enhancing the effectiveness of these medications. Additionally, she has developed self-microemulsifying drug delivery systems, which are designed to improve the solubility of pharmaceutical ingredients. These systems utilize a polyoxyethylene sorbitan fatty acid ester emulsifier, a fatty acid ester co-emulsifier, and an oil to enhance drug delivery.
Career Highlights
Polona Jurkovic is currently employed at Lek Pharmaceuticals D.d., where she continues to innovate in the field of pharmaceuticals. Her work has been instrumental in advancing drug formulations that improve patient outcomes.
Collaborations
Throughout her career, Polona has collaborated with notable colleagues, including Janez Kerc and Igor Legen. These partnerships have contributed to her success and the development of her patented technologies.
Conclusion
Polona Jurkovic is a trailblazer in the pharmaceutical industry, with a focus on innovative drug delivery systems and compositions. Her contributions are paving the way for advancements in medication effectiveness and patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile